Biblio
Export 230 results:
[ Author
Filters: First Letter Of Title is E [Clear All Filters]
“Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1213-1226, 2017.
, “Early-Stage Alzheimer's Disease Is Associated with Simultaneous Systemic and Central Nervous System Dysregulation of Insulin-Linked Metabolic Pathways.”, J Alzheimers Dis, vol. 68, no. 2, pp. 657-668, 2019.
, “Evolution of the Antidepressant Prescribing in Alzheimer's Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer's Disease (BNA).”, J Alzheimers Dis, vol. 53, no. 4, pp. 1365-73, 2016.
, “Exploring Reasons for Differential Vulnerability and Alzheimer's Disease Risk in Racial and Ethnic Minorities.”, J Alzheimers Dis, vol. 91, no. 1, pp. 495-506, 2023.
, “Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia.”, J Alzheimers Dis, vol. 62, no. 2, pp. 699-711, 2018.
, “Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer's Disease, and Other Neurodegenerative Disorders.”, J Alzheimers Dis, vol. 85, no. 3, pp. 975-992, 2022.
, “Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1131-1139, 2017.
, “Epileptic Prodromal Alzheimer's Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer's Disease to an Epileptic Variant?”, J Alzheimers Dis, vol. 52, no. 3, pp. 1125-33, 2016.
, “Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1325-1334, 2017.
, “The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief Report.”, J Alzheimers Dis, vol. 60, no. 2, pp. 341-347, 2017.
, “Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 921-32, 2016.
, “Effect of Advanced Glycation End Products on the Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 72, no. 1, pp. 191-197, 2019.
, “Exercise Training and Functional Connectivity Changes in Mild Cognitive Impairment and Healthy Elders.”, J Alzheimers Dis, vol. 57, no. 3, pp. 845-856, 2017.
, “Effects of a 3-Year Multi-Domain Intervention with or without Omega-3 Supplementation on Cognitive Functions in Older Subjects with Increased CAIDE Dementia Scores.”, J Alzheimers Dis, vol. 64, no. 1, pp. 71-78, 2018.
, “Early Diagnosis of Mild Cognitive Impairment due to Alzheimer's Disease Using a Composite of MemTrax and Blood Biomarkers.”, J Alzheimers Dis, vol. 94, no. 3, pp. 1093-1103, 2023.
, “The Effects of Pomegranate Seed Oil on Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1961-1970, 2024.
, “Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.”, J Alzheimers Dis, vol. 61, no. 1, pp. 53-65, 2018.
, “The Effects of an APOE Promoter Polymorphism on Human White Matter Connectivity during Non-Demented Aging.”, J Alzheimers Dis, vol. 55, no. 1, pp. 77-87, 2017.
, “An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 3, pp. 1085-1103, 2020.
, “Expression Changes in Mitochondrial Genes Affecting Mitochondrial Morphology, Transmembrane Potential, Fragmentation, Amyloidosis, and Neuronal Cell Death Found in Brains of Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 90, no. 1, pp. 119-137, 2022.
, “The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.”, J Alzheimers Dis, vol. 56, no. 2, pp. 805-815, 2017.
, “Effects of Exercise on Type 2 Diabetes Mellitus-Related Cognitive Impairment and Dementia.”, J Alzheimers Dis, vol. 59, no. 2, pp. 503-513, 2017.
, “Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.”, J Alzheimers Dis, vol. 78, no. 2, pp. 479-503, 2020.
, “Enhancing the Sensitivity of Memory Tests: Reference Data for the Free and Cued Selective Reminding Test and the Logical Memory Task from Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.”, J Alzheimers Dis, vol. 84, no. 1, pp. 119-128, 2021.
, “Early Life Stress Enhances Cognitive Decline and Alters Synapse Function and Interneuron Numbers in Young Male APP/PS1 Mice.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1097-1113, 2023.
,